MCH ADVISORY EQUITY RESEARCH
Institutional research — not investment advice ← Library
GL HOLD REF $173 PW TARGET $176 (+2% vs spot · 12m PWEV) +2% Single-name research · 25 August 2026
Equity ResearchFinancials · Life & Health Insurance
GL

Globe Life Inc (GL)

HOLD. 12-month probability-weighted target $176 (+2% vs spot). P/E Multiple explains 67% of Monte Carlo outcome variance.

HOLD RESEARCH mature cash generator 25 August 2026
$173 $176 (+2% vs spot · 12m PWEV) +2% 12-month probability-weighted
Expected return (1y)+1.6%
Margin of safety+9.9%
Quality79/100
Upside / downside1.4×
Downside probability+61%
Expected alpha (1y)-4.9%
Forward P/E10.1x
Independent DCF
Valuation confidencemedium
Key metric to watchConsolidated combined ratio (life + health underwriting margin proxy)
The case. narrow moat, mature cash generator
The problem. house above consensus; Consolidated combined ratio (life + health underwriting margin proxy)
What changes our mind. Consolidated combined ratio (life + health underwriting margin proxy) > deterioration such that the underwriting margin falls below ~24% (midpoint of the base 25.9% and soft-market 22.5% op-margin paths)

Model history: the direction implied by our targets has been right 43.6% of the time across 480 pre-registered anchors — below a coin flip. Treat the expected return as a distribution estimate, not a point forecast. This name's record ↓ · full record.

Not personalised investment advice · full disclosures in Part 9 below.

Contents
01Investment Decision

Investment Committee Summary

Rating HOLD
Internal 5-tier HOLD
Classification · conviction mature cash generator · medium
Evidence 8/8 load-bearing inputs sourced
Triangulated fair value $190 (+10% vs spot · triangulated FV)
12-mo scenario PWEV $176 (+2% vs spot · 12m PWEV)
Next catalyst 2026-10-05 — Ex-dividend $0.33/sh
Primary thesis-break Consolidated combined ratio (life + health underwriting margin proxy) > deterioration such that the underwriting margin falls below ~24% (midpoint of the base 25.9% and soft-market 22.5% op-margin paths) (2 consecutive prints)
Decision detail — rating tables & Research OS strip

Rating: HOLD

Internal 5-tier: HOLD · mature cash generator · analyst conviction: medium

Metric Value
Current Price $173
Triangulated Fair Value $190 (+10% vs spot · triangulated FV)
12-mo Scenario PWEV $176 (+2% vs spot · 12m PWEV)
Forward P/E 10.1x
Market Cap $13B
52-Week Range $116–$186 (high/low reconstructed from the stock's own adjusted-close history — the vendor's recorded range was stale)

EPS basis for the forward P/E and all scenario multiples: consensus forward EPS (broker-adjusted, non-GAAP).


Methodology: Valuation triangulated across four weighted anchors — an intrinsic DCF, a scenario-weighted PWEV, a Monte Carlo median (Student-t + regime switching) and a peer P/E re-rate. Anchors that share a market multiple are not independent evidence and are weighted as one view. Figures reconciled to Alpha Vantage 2026-08-24. Each chart below sits with the part of the thesis it evidences.

General research for a skeptical institutional reader. Not personalised investment advice; no position sizing or trade instructions. Figures as of the analysis date; verify before acting.

Decision Support — Research OS jump to detail ↓

Research conviction Exp. return (1y) Rules stance Preferred options Next catalyst
59.7/100 (57th pct) +2% 1yr expected Hold Covered Call 41d — Ex-dividend $0.33/sh

Full breakdown — conviction components, position sizing, probability-return distribution, decision rules, factor & portfolio interaction, options intelligence and the catalyst timeline — in the Decision Support sections below. Model output for research; not individualised advice.

📎 Download the full model (Excel) — DCF line items, scenarios, sensitivity, assumptions, and extended fundamentals.

Recommendation: HOLD

Balanced: triangulated fair value $190 (+10% vs spot); the outcome hinges on P/E Multiple. The debate is P/E Multiple — fundamentally a multiple/regime call.

02Thesis, Anti-Thesis & Variant View

Investment Thesis

At $173 (25 August 2026) and roughly 10x forward earnings, Globe Life is priced close to the life-insurer peer median — the market believes in a normalised combined ratio and steady float income, with little scope left for re-rating. The engine reaches a similar place from a different direction. The blended anchor is $190, +10% against spot, so the shares are fairly valued against intrinsic value, while the twelve-month base-case target of $172 and the probability-weighted value of $176 sit slightly the other side of the quote. That split is the point: the distribution is two-sided rather than skewed. Mid-cycle earnings power reconciles with the simulated median and the peer-multiple anchor corroborates it, but roughly a fifth of the tree sits on a structural underwriting, reserve and catastrophe reset that drags the mean down. The single most damaging risk is adverse reserve remeasurement: a discrete mortality or morbidity assumption change would compress the underwriting margin and the multiple at the same time.

Narrative drafted 2026-08-16 by claude-opus-5 under supervision; reviewed by Marinus 2026-08-16.

The dashboard below is the whole argument on one page: spot ($173) against each valuation anchor, the scenario tree, technicals and the options-implied move.

Integrated dashboard. The four weighted valuation anchors bracket the <img src=
Integrated dashboard. The four weighted valuation anchors bracket the $173 spot from $155 to $221 — fairly valued — spot brackets the blend.

Anti-Thesis (The Real Bear Case)

The highest-probability bear leg is the structural underwriting, reserve and catastrophe reset, carrying roughly a fifth of the weight. The mechanism is specific to a life insurer: reserve adequacy rests on long-dated mortality and morbidity assumptions, and a single adverse remeasurement forces both an earnings charge and a lower multiple, because the market begins to question the remaining reserve base rather than just this year's result. On that path the segment margin compresses well below today's 26%, earnings fall materially, and the rating de-rates toward a distressed multiple, taking the target beneath the 52-week low. Because underwriting and float income are the only earnings pillar, there is no offsetting segment to absorb the hit and no diversification argument to make. A strong return on equity offers a cushion, but the reset compounds a margin cut with a multiple cut inside the same reporting period.

Key Debate

P/E Multiple explains 67% of Monte Carlo outcome variance — i.e. value is set by the multiple the market will pay, a rate/sentiment regime bet as much as an earnings bet.

What the Market Is Pricing In

At the current price, the market pays 11.0× consensus forward EPS, and a peer median 9.9×.

Variant perception: the house view is below-consensus, and the thesis is primarily margin-driven.

Metric Consensus House Importance
Revenue 6.4 6.4 High
EPS 15.7 17.2 Medium
Target price 193.9 171.8 Medium
03Scenario & Valuation

Scenario Analysis

The scenario tree spans a structural 'Structural — Underwriting / Reserve / Catastrophe Reset' downside ($76.10) to a 'Bull — Re-Rate' bull case ($312); the probability-weighted blend (PWEV $176) is +2% versus spot.

Scenario Probability Target Return vs spot
Structural — Underwriting / Reserve / Catastrophe Reset 20% $76.10 -56%
Soft Market / Investment Loss 17% $127 -27%
Base — Mid-Cycle Combined Ratio 35% $184 +7%
Growth — Hard Market / Pricing + Float Income 20% $248 +43%
Bull — Re-Rate 8% $312 +80%
Probability-Weighted (PWEV) $176 +2%

Share-count charge: none applied. The probability-weighted value above is the gross per-share figure — no annual dilution is deducted — free cash flow net of SBC is $1.25B. SBC is therefore disclosed, not charged: read the per-share figures as before dilution.

Scenario rationale — the driver path behind every target:

  • Structural — Underwriting / Reserve / Catastrophe Reset (20%, $76.10). Structural impairment — underwriting / reserve / catastrophe reset: earnings AND the multiple compress together. Target sits below the 52-week low by construction.
  • Soft Market / Investment Loss (17%, $127). Cyclical downturn — premium growth + underwriting margin + investment income + reserves weakens for 1–2 years before normalising.
  • Base — Mid-Cycle Combined Ratio (35%, $184). Mid-cycle — normalised premium growth + underwriting margin + investment income + reserves; disciplined capital allocation; steady returns.
  • Growth — Hard Market / Pricing + Float Income (20%, $248). Upside — hard market + pricing lifts earnings above mid-cycle; the multiple expands modestly.
  • Bull — Re-Rate (8%, $312). Upside tail — sustained tight conditions or a structural re-rate on hard market + pricing.
Five-scenario tree. Probability-weighted targets around the <img src=
Five-scenario tree. Probability-weighted targets around the $173 spot; PWEV $176 (+2% vs spot · 12m). the payoff shows modest positive expectancy with material downside mass (range $76.10–$312)

Valuation Triangulation

Four weighted anchors — an intrinsic dcf, a scenario-weighted pwev, a monte carlo median (student-t + regime switching) and a peer p/e re-rate — read them with their basis in mind. The Monte Carlo, the DCF terminal and any peer re-rate key off a market multiple, so they are not fully independent; only discounted cash flows themselves are genuinely multiple-free. The discipline is to read the spread and weight the cash-based view, not to treat four numbers as four independent votes.

Method Basis Fair Value vs Spot Weight in this name's blend
Monte Carlo median (Student-t + regime) multiple $155 -11% 18% (declared 15%)
Peer P/E re-rate multiple $171 -1% 12% (declared 10%)
Peer EV/Revenue re-rate multiple $66.61 -62% 0% — cross-check only
Scenario PWEV multiple $176 +2% 29% (declared 25%)
Justified P/B (ROE-based) book value × ROE $221 +28% 41% (declared 35%)
Triangulated (weighted) $190 +10% 100%

The house blend DECLARES five anchor weights — DCF 35%, scenario PWEV 25%, Monte Carlo 15%, sum-of-parts 15%, peer re-rate 10%. For this name sum-of-parts is not computed, so 15% of the declared weight is redistributed across the anchors that exist — which is why the weights above differ from the declared ones. The fair value is unaffected by this disclosure; the blend has always worked this way.

Peer EV/Revenue re-rate — 0% weight: it duplicates the peer-multiple information already carried by the Peer P/E anchor while ignoring margin mix; weighting both would double-count the peer view. Shown as a cross-check.

Book Value, ROE & Capital Returns

For a bank or insurer the cash-flow DCF is the wrong intrinsic anchor — capital is the product. Value is set by return on equity vs cost of equity against book value: the Gordon-justified multiple is P/B = (ROE − g) / (COE − g).

Metric Value
Book value / share $78.12
Return on equity (ROE) 20.5%
Cost of equity (assumed) 9.5%
Current P/B 2.22x
Justified P/B (ROE-based) 2.83x
Justified value / share $221 (+28%)

ROE of 20.5% comfortably clears the ~10% cost of equity — which is why a premium justified P/B of 2.83x (vs 2.22x current) is warranted. The justified value sits +28% vs spot; that gap, plus the credit / underwriting cycle in the scenarios, is the debate. The Monte Carlo and scenario PWEV carry the earnings (P/E) view; this block carries the book-value view.

Monte Carlo — the outcome distribution

10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $155 and 39% of paths finish above spot. The variance decomposition shows the p/e multiple is the dominant swing factor (67% of variance). Value is a multiple bet: fundamentals move the answer far less than the rating does.

Monte Carlo distribution. Median <img src=
Monte Carlo distribution. Median $155; P(price > current) 39%. P10–P90: $89.87–$247.

Peer benchmarking — relative value

Against the peer cohort, re-rating to the peer-median forward multiple (P/E 9.9x) implies $171. A premium is only justified by superior growth/margins; otherwise it is multiple risk. Weighted just 12% so market sentiment does not set the fair value.

Cross-sectional peer benchmarking. Peer-median fwd P/E 9.9x → <img src=
Cross-sectional peer benchmarking. Peer-median fwd P/E 9.9x → $171; EV/Rev re-rate → $66.61.

Across all anchors the spread is 91% of the median — wide (genuine disagreement — the blend carries low valuation confidence).

Peer Quality & Weighting

Peer Fwd P/E Growth Op margin Quality Weight cap
AFL 14.5× 5% 30% segment 50%
MET 9.3× 5% 10% direct 100%
PRU 10.5× 5% 5% direct 100%
PFG 9.4× 5% 15% direct 100%

Quality-weighted forward P/E: 10.4× (simple median 9.9×). Direct peers count 100%, segment 50%, broad 25%.

Historical-range cross-check: 52-week range $116–$186, centre $147 (-15% vs spot); spot sits at the 82nd percentile of the range. Low-weight mean-reversion cross-check, not a fundamental anchor.

Risk / Reward & Margin of Safety

Metric Value
Upside to triangulated FV $190 (+10% vs spot · triangulated FV)
Downside to bear case (Structural — Underwriting / Reserve / Catastrophe Reset) $76.10 (-56% vs spot · bear scenario)
Reward/risk ratio 0.2×
Margin of safety (FV vs spot) +9%
P(price > spot) — Monte Carlo 39%

Reward/risk compares triangulated upside against the probability-weighted bear target, not the extreme tail. Bull case (Bull — Re-Rate): $312.

04Business & Financial Quality

Company Overview & Business Model

Globe Life Inc — FINANCIAL SERVICES · INSURANCE - LIFE. Globe Life is a financial services holding company that operates through its wholly owned subsidiaries providing life insurance, annuity, and supplemental health insurance products. The company is based in McKinney, Texas.

How it makes money.

Segment Rev mix Growth Op margin Key driver
Insurance (Underwriting + Float) 100% +5% 26% premium growth + underwriting margin + investment income + reserves

Edge. Narrow moat — Globe Life's edge is a captive/exclusive agency distribution model selling small-face life and supplemental health to middle-income households, giving persistency and float, but it is a commoditized product with no pricing monopoly, so the moat is narrow; a ~10.4x multiple is appropriate for a mid-cycle combined ratio, and any reserve/underwriting reset or agency-force disruption should push the multiple below the life-insurer median rather than support re-rating.

Revenue-Segment Breakdown

The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)

Segment Revenue Mix Growth Op margin EBIT Multiple Capex % Tag
Insurance (Underwriting + Float) $6.1B 100% 5% 26% $1.6B 10.0x 1% ESTIMATE
EBIT = segment revenue × operating margin (segment EBITDA not shown — per-segment D&A is not separately disclosed).

Named Exposures

Demand & pricing cycle (FACT/ESTIMATE)

Dimension Assessment
driver premium growth + underwriting margin + investment income + reserves
net_debt_or_cash_b -2.52

Capital intensity & shareholder returns (ESTIMATE)

Dimension Assessment
capex_pct_revenue 0.01
div_yield 0.0065

Structural risk vs optionality (INFERENCE)

Dimension Assessment
downside underwriting / reserve / catastrophe reset
upside hard market + pricing

Balance Sheet & Liquidity

Metric Value
Net debt $-15.4B — net cash
Net debt / EBITDA -9.18x
Interest coverage (EBIT / interest) 10.4x
Current ratio 9.66x
Cash & ST investments $18.0B

Balance-sheet data as of 2025-12-31 (Alpha Vantage).

Capital Allocation

Metric Value
Free cash flow $1.3B
Buybacks / dividends $0.9B / $0.1B
Total shareholder yield 7.3%
Payout as % of FCF 77.1%
Reinvestment (capex / OCF) 10.2%
Allocation stance returns-heavy

Free-Cash-Flow Quality

Metric Value
FCF margin 20.6%
FCF conversion (FCF / net income) 108.0%
FCF yield 9.5%
Capex intensity (capex / revenue) 2.3%
FCF − SBC (diagnostic) $1.2B
Capex split (maint / growth) 85% / 15% — Insurers are capital-light on PP&E; 'capex' is minimal (systems/facilities), and growth investment is really agent recruiting and float deployment rather than physical capex.

Accounting quality: SBC 1% of revenue; cash conversion (OCF/NI) 120% — cash-backed.

Competitive Moat

Moat sources:

  • Captive/exclusive agency distribution (American Income, Liberty National) with recurring persistency
  • Float from long-duration life/supplemental policies invested for spread income
  • Underwriting/actuarial data on a narrow middle-income niche
  • Offset: commoditized product, agent-recruiting dependence, and prior short-seller scrutiny on agency practices
05Earnings, Consensus & Catalysts

Earnings-Call Disconfirmation & Sentiment

Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.

Management vs analyst tone (2026Q2): management +0.34 vs analyst floor +0.00delta +0.34 (n=37 mgmt / 24 Q&A; 36th pctile across the S&P book, z -0.4).

Flag: TYPICAL — management-vs-analyst tone within the normal cross-sectional range.

Quarter Mgmt Analyst Delta
2026Q2 +0.34 +0.00 +0.34
2026Q1 +0.28 +0.00 +0.28
2025Q4 +0.27 +0.03 +0.24
2025Q3 +0.31 +0.05 +0.26

News (last 365d, 1250 articles): avg ticker sentiment +0.09 (bullish 18% / bearish 11%)

Consensus & Market Expectations

Reference Value
Street target (mean) $194 (+12% vs spot · street)
House target $172 (-11.4% vs street)
Sell-side coverage 11 analysts (SB 4 / B 4 / H 3 / S 0 / SS 0; net score 0.55)
Consensus FY EPS $15.71; house above (+9.4%)
Consensus FY revenue $6.4B; house in-line (-0.0%)

_Consensus figures: Alpha Vantage sell-side aggregates. Where the house view sits materially above or below the street, the divergence is itself a datum — see the thesis.

Catalyst Calendar

  • 2026-10-21 (~58d) — Quarterly earnings — est. EPS $4.83 (AV EARNINGS_CALENDAR)
  • 2027-02-10 (~170d) — Capital return / buyback authorization update (authored)

Forecast Track Record

  • EPS surprise: beat 50% of the last 8 quarters; average surprise +1.4%.
  • Prior-forecast backtest (12 snapshots, 2026-06-27→2026-08-20): directional hit-rate 100%; mean predicted -4.7% vs realised -4.0%. Disconfirming track record is reported, not suppressed.

Catalyst Timeline

6 catalysts in the next 90 days (of 15 tracked). Importance 1–3; confidence 0–1.

When Catalyst Type Importance Confidence
2026-09-16 (in 22d) FOMC rate decision + SEP dot plot macro ●● 0.8
2026-09-18 (in 24d) Quarterly options-expiry cluster (3rd Friday) opex_cluster 1.0
2026-10-05 (in 41d) Ex-dividend $0.33/sh dividend 0.9
2026-10-14 (in 50d) September CPI macro ●● 0.8
2026-10-21 (in 57d) Quarterly earnings earnings ●●● 0.95
2026-10-28 (in 64d) FOMC rate decision + press conference macro ●● 0.8
2026-12-09 (in 106d) FOMC rate decision + SEP dot plot macro ●● 0.8
2026-12-18 (in 115d) Quarterly options-expiry cluster (3rd Friday) opex_cluster 1.0
2027-01-27 (in 155d) FOMC rate decision + press conference macro ●● 0.8
2027-02-10 (in 169d) Capital return / buyback authorization update authored 0.7
2027-03-17 (in 204d) FOMC rate decision + SEP dot plot macro ●● 0.8
2027-03-19 (in 206d) Quarterly options-expiry cluster (3rd Friday) opex_cluster 1.0
2027-04-28 (in 246d) FOMC rate decision + press conference macro ●● 0.8
2027-06-09 (in 288d) FOMC rate decision + SEP dot plot macro ●● 0.8

_Sources: extended.catalysts, data/catalysts/.json, data/catalysts/macro.json, AV DIVIDENDS, opex 3rd-Friday calc.

06Risks & Falsification
Issue Probability Valuation sensitivity Horizon
State insurance-department market-conduct and agency-practice scrutiny medium (~40%) medium - reputational/agency-model risk; ~10% of FV 12-24m
Statutory capital / RBC and reserve-basis changes low (~30%) medium - affects payout capacity; ~10% of FV 12-24m

Probabilities and sensitivities are analyst estimates, not market-implied.

Scenario Macro & Key Risks

Scenario Macro assumption Key risk
Structural — Underwriting / Reserve / Catastrophe Reset Adverse mortality/morbidity or reserve inadequacy forces a combined-ratio reset while agency-practice scrutiny pressures the model. Earnings and multiple compress together below the life-insurer median.
Soft Market / Investment Loss Falling rates compress float spread income and a credit drawdown hits the investment portfolio. Spread income falls just as underwriting normalises, hitting both earnings legs.
Base — Mid-Cycle Combined Ratio Normalised combined ratio and steady float income at prevailing rates sustain low-single-digit book-value growth. Agent-count stagnation quietly caps future premium growth.
Growth — Hard Market / Pricing + Float Income Firm pricing plus higher reinvestment yields lift both underwriting margin and float income. Higher rates that help float income can coincide with weaker middle-income policy demand.
Bull — Re-Rate Sustained agent growth and clean underwriting earn a re-rate toward the higher end of the peer range. Any recurrence of agency-practice or reserve concerns reverses the re-rate quickly.

Decision Rules (Machine-Checked)

Stance: Hold — 0 bullish / 0 bearish / 0 caution rules triggered of 6 evaluable (0 lacked data).

Rule Condition Observed Triggered
R1-valuation-stretch expected return vs fair value < -12 (upside_pct) -0.77 no
R2-valuation-opportunity expected return vs fair value > 15 (upside_pct) -0.77 no
R3-street-revisions street net rating stance < -0.25 (extended.consensus.street_score) 0.55 no
R4-earnings-quality cash conversion of earnings < 80 (extended.accounting_quality.cash_conversion_pct) 120.2 no
R5-technical-breakdown price vs 200-day SMA < 0.85 (technicals.sma_200) 1.14 no
R6-vol-regime-shift IV/RV vol-risk premium > 1.4 (options_overlay.iv_rv) 0.85 no

Machine-checked rules over disclosed inputs. The authored falsification triggers elsewhere in this report are analyst judgment and are NOT evaluated here. The stance is a portfolio-management signal and does not modify the published research rating.

Reasons the Thesis Could Fail (Falsifiable)

Pre-registered signals that would break the thesis — each polices a specific scenario boundary and is checked at every earnings update:

  • Consolidated combined ratio (life + health underwriting margin proxy) > deterioration such that the underwriting margin falls below ~24% (midpoint of the base 25.9% and soft-market 22.5% op-margin paths) (2 consecutive prints). A sustained margin below the base/soft midpoint signals the cyclical-downturn path is materialising rather than mid-cycle normalisation, moving weight from the base toward the soft-market and structural scenarios.
  • Net policy obligation / reserve remeasurement charge > any material adverse remeasurement or reserve strengthening booked in the period (single event). Adverse reserve development is the mechanism of the structural-impairment scenario; a discrete strengthening charge is direct evidence the reset leg is live, not a soft-market blip.
  • Net investment income yield on the fixed-maturity portfolio < new-money yield falling below the level assumed to sustain the base op-margin (float income turning into a drag rather than a support) (2 consecutive prints). Float income is a load-bearing input to the op-margin path; a persistent decline in the reinvestment yield pulls the earnings profile toward the soft-market case.
  • Diluted book value per share (ex-AOCI) trend < sequential erosion below the reconciliation book value of $78.12/share driven by operating losses rather than capital returns (2 consecutive prints). Operating-driven book erosion (as distinct from buybacks) confirms capital is being consumed by underwriting/reserve losses, the pathway from the base into the structural scenario.
  • Return on equity (trailing four quarters) < ROE falling below the ~9.5% cost of equity in the reconciliation, versus the ~20.5% recorded (2 consecutive prints). ROE dropping toward or below cost of equity removes the justification for a mid-cycle multiple and is the trigger for the re-rate premium in the growth/bull paths to unwind.

Fact / Inference / Speculation

  • FACT: Spot $173; 52-week range $116–$186; engine rating HOLD; house target $172 (-1%). (source: Alpha Vantage 2026-08-24, 25 August 2026)
  • INFERENCE: Triangulated FV $190 (+10% vs spot · triangulated FV); the rating tracks the Monte-Carlo + scenario-PWEV core; the cash-flow anchor sits above the multiple-discipline core.
  • SPECULATION: At current prices the embedded bet is that the market keeps paying the current multiple through the capex cycle — a regime call the engine cannot verify from fundamentals alone.
07Portfolio & Options

Conviction Score

Research Conviction measures the strength and quality of the research setup — input coverage, financial quality, valuation support, process agreement. It is NOT the probability that the recommendation succeeds; the forecast track record section is the evidence on that.

59.7/100 (confidence band 49.1–70.3), 57th percentile of 858 covered names (as of 2026-08-24). Weighted composite under config ros-1.19.0 — every component and its inputs below.

Component Score (0–100) Weight Inputs
business quality 79 15% extended.fcf_quality.fcf_margin_pct, extended.balance_sheet.net_debt_to_ebitda, extended.accounting_quality.cash_conversion_pct
financial strength 83 10% extended.balance_sheet.net_debt_to_ebitda, extended.balance_sheet.interest_coverage
valuation 49 15% upside_pct
growth 52 10% reconciliation.ttm_revenue_billions, reconciliation.fy_guide_revenue_billions
earnings visibility 50 10% extended.forecast_accuracy.eps_surprise.beat_rate_pct
moat 55 10% enrichment.moat.rating
technical trend (heuristic — no validation record; weight change reserved for AM-060) 47 10% technicals.rsi, technicals.sma_50, technicals.sma_200
macro tailwinds 10% industry_context.house
risk profile 58 10% monte_carlo.prob_above_current, monte_carlo.p10, monte_carlo.p90, monte_carlo.median

Missing inputs (macro tailwinds) are excluded and the remaining weights renormalised; the confidence band widens accordingly.

Score history: 63.0 → 63.0 → 63.2 → 62.8 → 62.8 → 60.0 → 59.7 → 59.7.

Probability-Weighted Return Profile

Horizon: 1 year — at this horizon CAGR equals total return by definition. Expected values are the probability-weighted sums over the full scenario set below.

Scenario Probability Target Total return Contribution
Structural — Underwriting / Reserve / Catastrophe Reset 20% $76.10 -56.0% -11.2pp
Soft Market / Investment Loss 17% $127 -26.9% -4.6pp
Base — Mid-Cycle Combined Ratio 35% $184 +6.6% +2.3pp
Growth — Hard Market / Pricing + Float Income 20% $248 +43.2% +8.6pp
Bull — Re-Rate 8% $312 +80.1% +6.4pp
Aggregate Value
Expected return (gross, 1y) +1.6%
Expected return net of SBC dilution +1.6%
Outcome dispersion (σ, from MC p10–p90) 35.5%
Expected Sharpe (rf 4%) -0.07
Downside expectation (prob-weighted loss branches) -15.8%

The gross expected return is the probability-weighted scenario return (it reconciles to the gross PWEV); the diluted figure applies the SBC share-count charge and matches the published PWEV-based target.

Expected Alpha

Expected return minus the return this name is REQUIRED to deliver for its risk (1-year horizon). Constants are pre-registered (preregistered-static (amendment #2, 2026-07-29); not fitted to MCH outcomes).

Component Value
Expected return (gross, 1y) 1.6%
Risk-free rate 4.01% (1y proxy (3m/2y midpoint; AV lacks a 1y tenor), as of 2026-08-13)
Beta (shrunk, 1y vs SPY) 0.56 (as of 2026-08-24)
Equity risk premium 4.5%
Required return 6.5%
Expected alpha -4.9%
Alpha per unit risk (EA/σ) -0.14

A negative expected alpha does not change the rating — it says the expected return does not clear the risk-adjusted hurdle at today's price. Rating mechanics are unchanged by this section.

Probability Cross-Checks

Not authoritative. The scenario probabilities in this report are AUTHORED — a judgement about how the world might go, not a measurement. Nothing below modifies them, the target, the rating or any position size. These checks ask only whether anything outside our own model agrees with us; where it does not, that is information for the reader, not a correction we have quietly applied.

Cross-check Ours Comparator Reading
Scenario spread vs options market 40.6% (1σ) 17.6% implied broadly consistent with the market's implied uncertainty
Mass above spot: scenarios vs our own MC 63.0% 38.8% the scenario weights and the MC parameters disagree about our OWN view — this is a model-coherence issue, not a market disagreement
Realised scenario frequency 23 dated anchors 23 dated anchors available; realised-vs-prior comparison is now meaningful.

Authored set: 5 scenarios, probabilities summing to 1.0, mean target $175.84.

Flagged for review: internal coherence (authored mass vs Monte Carlo). A flag marks a disagreement worth understanding — it does not imply either side is wrong.

Factor Exposures

Cross-sectional percentiles over 858 covered names (style scores sector-demeaned; thematic = return-beta to the theme's proxy ETF). 50 = estate median.

Style Percentile Theme Percentile
Growth 46 AI 28
Value 94 Cloud 32
Quality 50 Semis 34
Momentum 72 Consumer 32
Low-Vol 63 Rates 34
USD 73
Energy 37

Market interaction: correlation vs SPY +0.20, vs QQQ +0.12 (trailing ~1y daily returns).

Options Intelligence

Preferred structure: Covered Call. The selector reads the equity view (direction) and the volatility surface — nothing here re-prices the chain.

  • range-bound with fair premium — harvest income against a holding
  • Direction neutral from the overlay conviction/rating (read-only input).
  • IV/RV at the 54th percentile of the cross-section → mid vol bucket. This is the measure that selects the structure above: it ranks how rich this name's implied vol is against its own realised vol, relative to other names.
  • Reported alongside and not used to select: this name's own ATM IV sits at the 21st percentile of its own month-end history (decile 3). The two measures disagree here — vol is high for this name by its own history while its options are not unusually rich against its realised vol. Where they diverge, the cross-sectional measure is the one acting.
  • IV term structure is in contango (longer-dated richer, slope +2.9pp) — favour longer-dated ownership (LEAPS) or calendars that are long the cheaper front.

IV term structure (contango, slope +2.9pp): 25-DTE 22% · 88-DTE 25% · 179-DTE 25%

Priced structure Value
Legs Short 185 C
Expiry 2026-09-18
Income yield 0.0%

Economics copied verbatim from the options overlay (priced from the listed chain (EOD marks)); the selector does not re-price.

Alternatives: Cash-Secured Put. IV rank shown via the name's own monthly IV history (advisory); structure selected on the cross-sectional IV/RV percentile. Model output for research and education only — not individualised investment advice. Position-sizing and stance figures are mechanical outputs of the disclosed rules and inputs; they do not consider any person's objectives, financial situation, or tax status.

Position Sizing Framework

Parameter Value
Initial position 0.50% NAV
Maximum position 0.83% NAV
Risk budget 1.40% NAV
Annualized outcome σ (MC) 35.5%
Indicative holding period 3–12 months
Liquidity high, ~$107M ADV (adv usd 21 (split-adjusted 21d average, AM-046)), ~0.1 days to exit
Rebalancing trigger position drifts ±25% from target weight, or the decision-rules stance changes

Model output for research and education only — not individualised investment advice. Position-sizing and stance figures are mechanical outputs of the disclosed rules and inputs; they do not consider any person's objectives, financial situation, or tax status.

Options Overlay

A defined-risk way to express the HOLD equity view. Chain as of 2026-08-24 — end-of-day marks — indicative, not executable quotes.

Market signals — ATM IV 22.0% (moderate regime) · expected move ±4.6% (2026-09-18) · put/call OI 0.10 · ATM Δ 0.45 / Θ -0.08 / ν 0.18 · next earnings 2026-10-21. Direction: NEUTRAL (implied return -2.7% to triangulated fair value $168.47).

Covered Call (if held) (Income / neutral) — Short 185 C · 2026-09-18 · premium $0.01 · yield 0.0% · priced from the listed chain (EOD marks)

Converts a near-fair holding into income by agreeing to sell at a higher strike — worth weighing when upside looks limited near fair value and being called away is acceptable. Illustrative — no outcome is implied or guaranteed.

Put Spread (income) (Income / would-own) — Short 160 P / Long 145 P · 2026-10-16 · net $0.75 · net entry $159.25 · yield 0.5% · RoR 5.0% · max loss $14.25 · priced from the listed chain (EOD marks)

Gets paid to wait for a lower entry, with the tail capped: the sold put collects premium while the cheaper long wing below it caps the maximum loss at the spread width — a defined-risk alternative to a naked cash-secured put.

Protective Collar (if held) (Hedge) — Long 155 P / Short 190 C · 2027-02-19 · net $1.77 · floor -10.0% · cap +10.0% · priced from the listed chain (EOD marks)

For a holder who wants to stay invested but cap risk: the sold call funds most of the protective put, fencing the position into a band — a way to ride out a de-rating without selling.

Indicative options structures — a defined-risk expression of the equity view, model-and-market illustrated from the last-close chain. NOT personalised advice or an executable quote; premiums, IV and greeks move intraday. Options carry the risk of total loss of premium. Not a registered financial adviser.

08Model Transparency

Rating Bridge

Rating = HOLD because:

  • Probability-weighted scenario value implies +2% vs spot
  • Monte Carlo median implies -11% vs spot
  • DCF fair value implies +28% vs spot
  • Bear case (Structural — Underwriting / Reserve / Catastrophe Reset) downside is -56% vs spot
  • Net: reward/risk of 0.2× is not asymmetric enough for a Buy and not impaired enough for a Sell — hence Hold.

Assumption Register

Assumption Value Used in Source
SBC dilution 0.0%/yr PWEV, MC, DCF (charged once) estimate (from SBC/rev)
EPS basis consensus forward EPS (broker-adjusted, non-GAAP) all forward P/E & scenario multiples definition

Inputs, Sources & Confidence

Every load-bearing input, labelled by type and confidence. (reported fact · company guidance · consensus estimate · market data · house estimate · inference.)

Input Value Type Source Confidence Used in
Revenue TTM $6.1B reported fact 10-K/10-Q via AV High Forecast base, EV/Rev
FY+1 guided revenue $6.4B company guidance Company guidance Medium Forecast, SoP
Consensus FY EPS $15.7103 consensus estimate Sell-side consensus via AV Medium Variant perception
Diluted shares 0.076B reported fact 10-K via AV High Market cap, per-share
Net debt / cash $-15.424B reported fact Balance sheet via AV High EV, DCF equity bridge

Research Provenance

Field Value
Quantitative engine mch_stock_engine v2.0
Research OS config ros-1.19.0
Analysis as-of 2026-08-25 (prices 2026-08-24)
Narrative authorship claude-opus-5 · Claude Code, supervised, drafted 2026-08-16
Human review Marinus 2026-08-16
Evidence 8/8 load-bearing inputs sourced; 13/14 mandated claims cited
QA scanned post-emit by the document-QA layer; the publication label (Draft / Research / Decision-level) is stamped on the published page, not authored here

Load-Bearing Assumptions

DCF inputs (WACC, terminal multiple) are not applicable to this name's valuation adapter; triangulation leans 41% on DCF, 29% on PWEV, 18% on the Monte Carlo median, 12% on peer-implied value.

09Appendix & Audit Trail
Appendix & audit trail — source log, data provenance, disclosures

Source Log

Source Type Date Used for Reference
Alpha Vantage — GLOBAL_QUOTE / OVERVIEW market data 2026-08-24 Price, market cap, EV, forward P/E Alpha Vantage 2026-08-24
MCH engine — trailing 252 adjusted closes derived 2026-08-24 52-week range (vendor's recorded range was stale and was replaced) trailing 252 sessions of own close history; config value was stale
Company income statement (10-K / 10-Q) via Alpha Vantage reported fact 2026-08-24 Revenue, gross/operating margin, EBIT, interest expense INCOME_STATEMENT / latest annual
Company balance sheet (10-K / 10-Q) via Alpha Vantage reported fact 2026-08-24 Cash, debt, net debt, leases, equity, coverage BALANCE_SHEET / latest annual
Company cash-flow statement (10-K / 10-Q) via Alpha Vantage reported fact 2026-08-24 Operating cash flow, capex, FCF, buybacks, dividends, SBC CASH_FLOW / latest annual
Company earnings releases via Alpha Vantage reported fact 2026-08-24 Reported EPS, surprise history EARNINGS / quarterly
Sell-side consensus via Alpha Vantage consensus estimate 2026-08-24 Forward revenue/EPS consensus, analyst count EARNINGS_ESTIMATES
Earnings calendar via Alpha Vantage market data 2026-08-24 Next earnings date, catalyst timing EARNINGS_CALENDAR
Company guidance company guidance 2026-08-24 FY guided revenue / non-GAAP EPS basis company guidance / earnings call
MCH segment model (from filings & disclosures) house estimate 2026-08-24 Segment revenue, margins, multiples, AI decomposition company_context (authored, tagged)
MCH qualitative analysis inference 2026-08-24 Moat, regulatory risk, scenario macro, catalysts company_context enrichment (authored)
MCH investment thesis & falsification triggers house estimate 2026-08-24 Thesis, anti-thesis, thesis-break signals authored §5.3

Citation coverage: 13/14 mandated claims sourced. Filing URLs are not available via the market-data provider; company statements are cited as 10-K/10-Q via Alpha Vantage.

Data Sources

  • Prices, fundamentals, options chain, earnings — Alpha Vantage.
  • Company filings (10-K / 10-Q)SEC filings via EDGAR.

Disclosures & Limitations

This report is for informational and research purposes only. It is not personalised investment advice and does not consider any investor's objectives, financial situation, risk tolerance, tax position, or liquidity needs.

  • This report is produced by the MCH Advisory quantitative research engine — valuation, scenarios, Monte Carlo and the decision layer are generated systematically from the disclosed inputs and the archetype/industry driver sets, and reviewed rather than written name-by-name. Every figure reconciles to the appendix and every score exposes its inputs.
  • No suitability assessment has been performed for any individual.
  • Market data may be delayed or inaccurate; figures are as of the analysis date.
  • Model outputs (fair values, targets, scenario probabilities) are estimates and may be wrong.
  • Forecasts are uncertain; past performance is not indicative of future returns.
  • The author or publisher may hold positions in securities mentioned.
  • Users should verify information against primary sources (company filings) before acting.
  • Investing involves risk of loss; there is no guarantee any target price is achieved.
  • Ratings follow a defined research methodology (12-month expected-return thresholds), not individual circumstances.

Forecast record. Across 480 pre-registered anchors, the direction implied by our targets has been right 43.6% of the time — below the 50% a coin flip would give, with a Brier score of 0.268 against 0.25 for that same coin flip (lower is better). The tier-level picture is mixed: sector-relative alpha on SELL calls excludes zero, on BUY calls it does not, and the flattering aggregate is carried by HOLD, which counts as a hit merely for tracking its benchmark. Read the target below with that in mind — and see the full accuracy record. Samples are thin and windows short; nothing here is settled in either direction.

Disclosures. This document is produced by MCH Advisory Services for informational and quantitative-research purposes only. It does not constitute investment, financial, legal or tax advice, nor an offer or solicitation to buy or sell any security. Price targets and probabilities are model outputs, not guarantees; past performance and backtested/simulated figures are not reliable indicators of future results. The author may hold positions in instruments mentioned and is not a registered financial adviser. Conduct your own due diligence and consult a qualified, registered adviser before making any investment decision.